EP 1286974 A2 20030305 - MEDICAMENT FOR VIRAL DISEASES
Title (en)
MEDICAMENT FOR VIRAL DISEASES
Title (de)
ISOXAZOLE GEGEN VIRALE ERKRANKUNGEN
Title (fr)
MEDICAMENT POUR MALADIES VIRALES
Publication
Application
Priority
- DE 10009408 A 20000228
- DE 10032874 A 20000706
- EP 0101825 W 20010219
Abstract (en)
[origin: WO0164755A2] Isoxazoles are highly effective anti-viral agents. Combinations of isoxazoles, dihydropyrimidines and/or lamivudine and, optionally, interferon inhibit the proliferation of HBV viruses better than conventional agents.
IPC 1-7
IPC 8 full level
A61K 31/42 (2006.01); A61K 31/4439 (2006.01); A61K 31/506 (2006.01); A61K 31/513 (2006.01); A61K 38/21 (2006.01); A61K 45/00 (2006.01); A61P 1/16 (2006.01); A61P 31/12 (2006.01); A61P 43/00 (2006.01); C07D 261/08 (2006.01); C07D 261/14 (2006.01); C07D 261/18 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP KR US)
A61P 1/16 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 261/08 (2013.01 - EP KR US); C07D 261/14 (2013.01 - EP KR US); C07D 261/18 (2013.01 - EP KR US)
Citation (search report)
See references of WO 0164755A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0164755 A2 20010907; WO 0164755 A3 20020620; AU 3739801 A 20010912; BR 0108723 A 20021203; CA 2401405 A1 20010907; CN 1406233 A 20030326; EP 1286974 A2 20030305; IL 151188 A0 20030410; JP 2003526639 A 20030909; KR 20020079963 A 20021021; MX PA02008418 A 20030212; PL 365124 A1 20041227; TR 200201954 T2 20021223; US 2003187028 A1 20031002
DOCDB simple family (application)
EP 0101825 W 20010219; AU 3739801 A 20010219; BR 0108723 A 20010219; CA 2401405 A 20010219; CN 01805765 A 20010219; EP 01909773 A 20010219; IL 15118801 A 20010219; JP 2001564248 A 20010219; KR 20027011205 A 20020827; MX PA02008418 A 20010219; PL 36512401 A 20010219; TR 200201954 T 20010219; US 22011003 A 20030121